ArticleERJ open research2023
Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort.
Article in ERJ open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 45 citations in OpenAlex.
- A 10-year nationwide analysis of nocturnal device prescriptions for sleep apnea in France.Sleep & breathing = Schlaf & Atmung · 2026Article
- Review
- Article
- Time to diagnosis and treatment of obstructive sleep apnoea using mandibular jaw movement monitoring versus polysomnography: an open-label, multicentre, randomised, controlled trial.The Lancet regional health. Europe · 2026Article
- Incidence, Characteristics, and Management Pathways of Obstructive Sleep Apnea in England: A 10-Year Retrospective Cohort Study.CHEST pulmonary · 2026Article
- Sex-difference in chewing difficulty and the risk of obstructive sleep apnea among middle-aged and older adults.Sleep & breathing = Schlaf & Atmung · 2026Article
- Article
- Proposition of a new, minimally-invasive, software smartphone device to predict sleep apnea and its severity.Sleep & breathing = Schlaf & Atmung · 2025Observational
- Changes in the gut microbiota in mice exposed to chronic intermittent hypoxia.Journal of medical microbiology · 2025Article
- Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea.ERJ open research · 2025Article
- Impact of Asthma and Obstructive Sleep Apnea on Central Airways Resistance During Pregnancy.Lung · 2025Article
- Apnea detection using wrist actigraphy in patients with heterogeneous sleep disorders.Scientific reports · 2025Article
- An Automated Algorithm for Obstructive Sleep Apnea Detection Using a Wireless Abdomen-Worn Sensor.Sensors (Basel, Switzerland) · 2025Article
- Article
- Community pharmacies in early detection of obstructive sleep apnea: findings from a nationwide survey.Frontiers in public health · 2025Article
- Sleep and periodontal health.Periodontology 2000 · 2024Review
- Validation of a Textile-Based Wearable Measuring Electrocardiogram and Breathing Frequency for Sleep Apnea Monitoring.Sensors (Basel, Switzerland) · 2024Article
- Long daytime napping: A silent danger for hypertensive individuals.European journal of neurology · 2024Article
- Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea.Journal of the American Heart Association · 2024Article
- Sex-specific associations between habitual snoring and cancer prevalence: insights from a US Cohort Study.Sleep advances : a journal of the Sleep Research Society · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnoea (OSA) is associated with increased morbidity and mortality. Although the disorder has been well studied in selected high-risk populations, few data exist on its prevalence in the general population. We aimed to assess the prevalence and determinants of OSA in France. Methods: Data from participants of the French population-based CONSTANCES cohort aged 18-69 years at inclusion and being treated for sleep apnoea or screened for OSA in 2017 using the Berlin Questionnaire were analysed. Weighted analyses were performed to provide recent and representative results in the general population. Results: Among 20 151 participants, the prevalence of treated sleep apnoea was 3.5% (95% CI 3.0-3.9%). The prevalence of untreated subjects with a positive Berlin Questionnaire was 18.1% (95% CI 17.3-19.2%) for a total weighted prevalence of treated sleep apnoea or high risk of OSA of 20.9% (95% CI 20.0-21.9%). Regarding prevalence of OSA symptoms, it was 37.2% (95% CI 36.1-38.3%) for severe snoring and 14.6% (95% CI 13.8-15.5%) for hypersomnolence. In multivariable logistic regression analysis, male sex, age, previous cardiovascular events, smoking, low educational level, low physical activity and depressive symptoms were associated with having either treated sleep apnoea or a positive Berlin Questionnaire. Conclusion: In this large French population-based cohort, one in five participants had a high likelihood of OSA, whereas only 3.5% were treated for the disorder, suggesting major underdiagnosis in the general population. OSA diagnosis should be considered more often in people with risk factors such as depressive symptoms as well as unhealthy behaviours and socioeconomic conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.